期刊文献+

白细胞介素-18抑制小鼠Lewis肺癌生物学活性及其机制 被引量:2

原文传递
导出
摘要 80年代中期形成的生物调节理论产生了第四大肿瘤疗法-肿瘤生物治疗,在抗肿瘤基础研究与临床实践上愈益显示出其独特的疗效,可望为肿瘤防治开辟一个新的局面。白细胞介素-18(IL-18)是新近发现的多效能免疫调节细胞因子。本实验旨在观察其对小鼠Lewis肺癌移植瘤增殖生长与转移的抑制作用,并探讨其作用机制。
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第5期670-671,共2页 Chinese Journal of Experimental Surgery
基金 福建省卫生厅青年科研课题立项(2005-2-29) 福建省自然科学基金资助项目(2006J0342)
  • 相关文献

参考文献2

二级参考文献76

  • 1顾健人,杨胜利.要用系统性疾病的观念重新认识癌症[J].中华医学杂志,2005,85(8):505-507. 被引量:13
  • 2American Cancer Society. Cancer facts and figures 2006. [ 2006- 07-31 ]. http://www, cancer, org/downloads/STT/CAFF 2006 PWSecured. 被引量:1
  • 3Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population- based trends in cancer treatment [ J ]. J Natl Cancer Inst, 2005, 97(19) : 1407-1427. 被引量:1
  • 4Kalluri R, Zeisberg M. Fibroblasts in cancer [ J ]. Nat Rev Cancer, 2006, 6(5) : 392-401. 被引量:1
  • 5Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer[ J ]. J Cell Biochem, 2007, 101 (4) : 805-815. 被引量:1
  • 6Sell S. Stem cell origin of cancer and differentiation therapy [ J ]. Crit Rev Oncol Hematol, 2004, 51 (1) : 1-28. 被引量:1
  • 7Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukacmia after transplantation into SCID mice[ J ]. Nature, 1994, 367(6464) : 645-648. 被引量:1
  • 8Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties[J]. Hepatology, 2006, 44( 1 ) : 240-251. 被引量:1
  • 9Yin S, Li J, Hu C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity [ J ]. Int J Cancer, 2007, 120(7) :1436-1442. 被引量:1
  • 10Hill RP. Identifying cancer stem cells in solid tumors: case not proven[J]. Cancer Res, 2006, 66(4) : 1891-1895. 被引量:1

共引文献30

同被引文献23

  • 1de Jonge H,Kuypers DR.Pharmacogenetics in solid organ transplantation:current status and future directions.Transplant Rev (Orlando),2008,22:6-20. 被引量:1
  • 2Li Y,Zou Y,Cai B,et al.The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients.Gene,2012,491:251-255. 被引量:1
  • 3Zhang XQ,Wang ZW,Fan JW,et al.The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.Ther Drug Monit,2012,34:126-133. 被引量:1
  • 4Rojas LE,Herrero MJ,Bos6 V,et al.Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A > G genotype on tacrolimus dose requirements in liver transplantation.Pharmacogenet Genomics,2013 Jul 18.[Epub ahead of print]. 被引量:1
  • 5MacPhee IA.Pharmacogenetic biomarkers:cytochrome P450 3A5.Clin Chim Acta,2012,413:1312-1317. 被引量:1
  • 6Harada M,Obara K,Hirota T,et al.A functional polymorphism in IL-18 is associated with severity of bronchial asthma.Am J Respir Crit Care Med,2009,180:1048-1055. 被引量:1
  • 7DickmannLJ,Patel SK,Wienkers LC,et al.Effects of interleukin 1β (IL-1β) and IL-1 β/interleukin 6 (IL-6) combinations on drug metabolizing enzymes in human hepatocyte culture.Curr Drug Metab,2012,13:930-937. 被引量:1
  • 8Tsutsui H,Nakanishi K.Immunotherapeutic applications of IL-18.Immunotherapy,2012,4:1883-1894. 被引量:1
  • 9Zhang X,Wang Z,Fan J,et al.Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.Eur J Clin Pharmacol,2011,67:803-813. 被引量:1
  • 10Chia CS,Ban K,Ithnin H,et al.Expression of interleukin-1 8,interferon-gamma and interleukin-10 in hepatocellular carcinoma.Immunol Lett,2002,84:163-172. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部